Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMEXHS LIMITED Director's Dealing 2020

Nov 5, 2020

65120_rns_2020-11-05_152fc4a5-7c74-4744-8913-e555fbf8bff9.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [117 x 31] intentionally omitted <==

6 November 2020

ASX ANNOUNCEMENT

Capital Consolidation

IMEXHS Limited (“ IMEXHS ” or “the Company ”) is pleased to confirm that the consolidation of the Company’s issued shares and options on a 50 to 1 basis approved at the EGM of shareholders held on 30 October 2020 has now been completed ( Consolidation ).

Following the Consolidation, the total number of securities on issue were reduced as set out in the table below. The Consolidation applied equally to all securityholders (subject only to the rounding of fractions), having no material effect on the percentage interest of each securityholder.

Pre-Consolidation
shares
Post-Consolidation
shares
Pre-Consolidation
options
Post-Consolidation
options
1,484,990,526 29,699,842 309,500,000 6,190,003

New holding statements have been despatched today and normal trading of the Company’s securities on a post-consolidation basis will commence on 9 November 2020.

The changes to the holdings of each Director as a result of the consolidation is advised in the attached Change of Directors’ Interest Notices.

Authorised for release by the Company Secretary of IMEXHS Limited.

-ENDS-

For more information, please contact:

Media and Investor Relations

Françoise Dixon, Citadel-MAGNUS E: [email protected]

T: +61 412 292 977

Business Inquiries

Reena Minhas – CFO & Company Secretary IMEXHS E: [email protected] T: +61 (0)2-9030-0040

IMEXHS Limited ABN 60 096 687 839 Imaging Experts and Healthcare Services Pty Ltd ABN 18 624 772 756 122 O’Riordan Street, Mascot NSW 2020 Tel: +61 2 9030 0040

==> picture [117 x 31] intentionally omitted <==

About IMEXHS

IMEXHS Limited [ASX: IME] is a leading imaging Software-as-a-Service (SaaS) and ancillary solutions provider with over 120 customers on recurring contracts in over 250 sites, and distributors in 15 countries. Founded in 2012, IMEXHS is known for its innovation in the imaging services market, offering flexible and scalable imaging solutions via its HIRUKO branded suite of solutions for next generation Picture Archiving and Communications System (PACS) and integrated medical imaging systems (including a Radiology Information System (RIS), a Cardiology Information System (CIS) and an Anatomical Pathology Laboratory Information System (APLIS)). The HIRUKO™ system is completely cloud-based, vendor neutral and zero footprint with no need for installed software. The IMEXHS products are designed to increase productivity and save money for end users, with a scalable platform that is configured for the future and enhances patient outcomes. For more information, visit www.imexhs.com

IMEXHS Limited ABN 60 096 687 839 Imaging Experts and Healthcare Services Pty Ltd ABN 18 624 772 756 122 O’Riordan Street, Mascot NSW 2020 Tel: +61 2 9030 0040

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity ImExHS Limited
ABN 60 096 687 839

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Douglas Flynn
Date of last notice 7 October 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances
giving rise to the relevant interest.
1.
DR & LC Flynn Nominees Pty Limited A/C> - Mr Flynn is a director of the trustee and a
beneficiary of the super fund
2.
Dai Yat Pty Ltd . Mr Flynn is a director
and beneficiary
Date of change 6 November 2020
No. of securities held prior
to change
1.
25,582,467 fully paid ordinary shares
2,417,000 options exercisable at 2.5 cents, expiring
31/3/2021
8,000,000 options exercisable at 5.5 cents, expiring
12/3/2027
8,000,000 options exercisable at 7 cents, expiring
12/3/2027
12,000,000 options exercisable at 3 cents, expiring
12/3/2027
2.
1,000,000 fully paid ordinary shares
Class Fully paid ordinary shares and options
Number acquired N/A
Number disposed N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
includes brokerage/gst
Note: If consideration is non-cash, provide
details and estimated valuation
N/A
No. of securities held after
change
1.
511,649 fully paid ordinary shares
48,340 options exercisable at $1.25, expiring 31/3/2021
160,000 options exercisable at $2.75, expiring 12/3/2027
160,000 options exercisable at $3.50, expiring 12/3/2027
240,000 options exercisable at $1.50, expiring 12/3/2027
2.
20,000 fully paid ordinary shares
Nature of change
Example: on-market trade, off-market trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back
Consolidation of securities on a 50 to 1 basis in accordance with
the consolidation of securities approved by shareholders at the
General Meeting held on 30 October 2020.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to whichtheinteresthas changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity ImExHS Limited
ABN 60 096 687 839

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director German Arango
Date of last notice 29 August 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances
giving rise to the relevant interest.
Digital Imaging Solutions S.A.S. – German Arango is the
controlling shareholder
Date of change 6 November 2020
No. of securities held prior
to change
157,525,160 fully paid ordinary shares
15,287,254 Class A Consideration Options unlisted options at
$0.05 expiring 30 June 2021
15,287,254 Class B Consideration Options unlisted options at
$0.0375 expiring 28 August 2023, subject to
vesting conditions
15,287,254 Class B Consideration Options unlisted options at
$0.0375 expiring 28 August 2023, subject to
vesting conditions
Class Fully paid ordinary shares and options
Number acquired N/A
Number disposed N/A
Value/Consideration
includes brokerage/gst
Note: If consideration is non-cash, provide
details and estimated valuation
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after
change
3,150,503
fully paid ordinary shares
305,745
Class A Consideration Options unlisted options at
$2.50 expiring 30 June 2021
305,745
Class B Consideration Options unlisted options at
$1.875 expiring 28 August 2023, subject to vesting
conditions
305,745
Class B Consideration Options unlisted options at
$1.875 expiring 28 August 2023, subject to vesting
conditions
Nature of change
Example: on-market trade, off-market trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back
Consolidation of securities on a 50 to 1 basis in accordance with
the consolidation of securities approved by shareholders at the
General Meeting held on 30 October 2020.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to whichtheinteresthas changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts
detailed above traded during a+closed period
where prior written clearance was required?
No
If so, was prior written clearance provided to allow
the trade to proceed during this period?
N/A
If prior written clearance was provided, on what
date was this provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity ImExHS Limited
ABN 60 096 687 839

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Damian Banks
Date of last notice 16 September 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances
giving rise to the relevant interest.
1. HSBC Custody Nominees (Australia) Limited held on
behalf of Damisuper Pty Ltd Fund> of which Damian Banks is a Director of the trustee
and a beneficiary of the super fund
2. Damian Eric Banks & Michelle Anne Banks A/C> -beneficiary
Date of change 6 November 2020
No. of securities held prior
to change
1. 16,083,000 fully paid ordinary shares
2. 2,417,000 options exercisable at $0.025, expiring 31/3/2021
Class Fully paid ordinary shares and options
Number acquired N/A
Number disposed N/A
Value/Consideration
includes brokerage/gst
Note: If consideration is non-cash, provide
details and estimated valuation
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after 1. 321,660 fully paid ordinary shares

change 2. 48,340 options exercisable at $1.25, expiring 31/3/2021 Nature of change Consolidation of securities on a 50 to 1 basis in accordance with

Example: on-market trade, off-market trade, the consolidation of securities approved by shareholders at the exercise of options, issue of securities under

dividend reinvestment plan, participation in General Meeting held on 30 October 2020. buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts
detailed above traded during a+closed period
**where prior written clearance was required? **
No
If so, was prior written clearance provided to allow
the trade to proceed during this period?
N/A
If prior written clearance was provided, on what
date was this provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity ImExHS Limited
ABN 60 096 687 839

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Douglas Lingard
Date of last notice 2 November 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances
giving rise to the relevant interest.
1. Ilewise Pty Ltd (director related
entity and beneficiary)
2. Domatorisaro Pty Limited (director related entity)
3. Ilewise Pty Ltd (director
related entity and beneficiary)
Date of change 6 November 2020
No. of securities held prior
to change
Direct
2,000,000 options exercisable at $0.053 expiring 9/12/2023 and
subject to vesting conditions.
Indirect
1. 9,000,000 fully paid ordinary shares
2,416,000 options exercisable at $0.025, expiring 31/3/2021
2. 40,000,000 options exercisable at $0.054, expiring 31/3/2022
3. 16,666,667 fully paid ordinary shares
Class Full paid ordinary shares and options
Number acquired N/A
Number disposed N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
includes brokerage/gst
Note: If consideration is non-cash, provide
details and estimated valuation
N/A
No. of securities held after
change
Direct
40,000 options exercisable at $2.65 expiring 9/12/2023 and
subject to vesting conditions.
Indirect
1. 180,000 fully paid ordinary shares
48,320 options exercisable at $1.25, expiring 31/3/2021
2. 800,000 options exercisable at $2.70, expiring 31/3/2022
3. 333,333 fully paid ordinaryshares
Nature of change
Example: on-market trade, off-market trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back
Consolidation of securities on a 50 to 1 basis in accordance with
the consolidation of securities approved by shareholders at the
General Meeting held on 30 October 2020.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Note: In the case of a company, interests which come within
disclosed in this part.
paragraph (ii) of the definition of “notifiable interest of a director” should be
Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity ImExHS Limited
ABN 60 096 687 839

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Carlos Jaime Palacio
Date of last notice 29 August 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances
giving rise to the relevant interest.
1. Irukandji Investments Pty Ltd (A.C.N. 618 697 359) ATF The
Longreach Family Trust (A.B.N. 12 909 663 764) – This entity is not
controlled by Carlos Palacio. However, Mr Palacio is a named
beneficiary (amongst several others) under this family trust and
accordingly these securities have only been included in this notice for
good corporate governance purposes.
2. Rio Negro Pty Ltd (A.C.N. 620 274 759) ATF the Medallo Trust
(A.B.N. 98 872 197 438 – This entity is not controlled by Carlos
Palacio. However, Mr Palacio is a named beneficiary (amongst
several others) under this family trust and accordingly these securities
have only been included in this notice for good corporate governance
purposes.
Date of change 6 November 2020
No. of securities held prior
to change
1. 59,391,800
fully paid ordinary shares
5,763,762
Class A Consideration Options unlisted options
at $0.05 expiring 30 June 2021
5,763,762
Class B Consideration Options unlisted options at
$0.0375 expiring 28 August 2023, subject to
vesting conditions
5,763,762
Class B Consideration Options unlisted options at
$0.0375 expiring 28 August 2023, subject to
vesting conditions
2. 44,441,800
fully paid ordinary shares
4,312,918
Class A Consideration Options unlisted options
at $0.05 expiring 30 June 2021
4,312,918
Class B Consideration Options unlisted options at
$0.0375 expiring 28 August 2023, subject to
vesting conditions
4,312,918
Class B Consideration Options unlisted options at
$0.0375 expiring 28 August 2023, subject to
vesting conditions
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class Fully paid ordinary shares and options
Number acquired N/A
Number disposed N/A
Value/Consideration
includes brokerage/gst
Note: If consideration is non-cash, provide
details and estimated valuation
N/A
No. of securities held after
change
1. 1,187,836
fully paid ordinary shares
115,275
Class A Consideration Options unlisted options
at $2.50 expiring 30 June 2021
115,275
Class B Consideration Options unlisted options at
$1.875 expiring 28 August 2023, subject to
vesting conditions
115,275
Class B Consideration Options unlisted options at
$1.875 expiring 28 August 2023, subject to
vesting conditions
2. 888,836
fully paid ordinary shares
86,258
Class A Consideration Options unlisted options
at $2.50 expiring 30 June 2021
86,258
Class B Consideration Options unlisted options at
$1.875 expiring 28 August 2023, subject to
vesting conditions
86,258
Class B Consideration Options unlisted options at
$1.875 expiring 28 August 2023, subject to
vesting conditions
Nature of change
Example: on-market trade, off-market trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back
Consolidation of securities on a 50 to 1 basis in accordance with the
consolidation of securities approved by shareholders at the General
Meeting held on 30 October 2020.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to whichtheinteresthas changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
N/A
Interest after change N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts
detailed above traded during a+closed period
where prior written clearance was required?
No
If so, was prior written clearance provided to allow
the trade to proceed during this period?
N/A
If prior written clearance was provided, on what
date was this provided?
N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 3